US Futures Slightly Lower Amid Jobless Beat; Wal-Mart Drops as Weather Hurts Q1

U.S. stock futures were slightly lower before the market opened, having gained some ground after positive consumer spending and jobless claims data. The main futures indicators were down while the Nasdaq 100 pre-market indicator was higher by nearly a third of a percent. Meanwhile, Wal-Mart dropped as Q1 earnings disappointed the market.

In economic data today, the April consumer price index rose 0.3% from March, as expected, according to Econoday data. CPI, excluding food and energy, was higher 0.2% from March compared to the expected 0.1% gain.

Also out at 08:30 a.m. was the weekly jobless claims, at 297,000 compared to the 317,000 consensus. Meanwhile, the Empire State manufacturing index for May jumped to 19.01 compared to the 5.00 consensus.

At 09:15 a.m., industrial production is expected to be unchanged in April over March, while the capacity utilization rate is also seen unchanged at 79.2%. Manufacturing is expected to have gained 0.4%. Later, at 10:00 a.m., the NAHB housing market index for May is seen gaining to 49.00 from 47.00 in April.

In equities, Wal-Mart ( WMT ) was down 3% after severe weather had a negative impact on Q1 EPS, even as sales rose 0.8%. Cisco ( CSCO ) was higher nearly 8% after releasing a fiscal Q3 beat after the market close on Wednesday.


-Dow Jones Industrial down 0.19%

-S&P 500 futures down 0.20%

-Nasdaq 100 futures down 0.11%

-Nasdaq-100 Pre-Market Indicator up 0.29%


Nikkei down 0.75%

Hang Seng up 0.66%

Shanghai Composite down 1.30%

FTSE-100 down 0.07%

DAX-30 down 0.06%


(+/-) Large cap tech: mixed

(+) Chip stocks: unchanged to higher

(-) Software stocks: unchanged to lower

(+) Hardware stocks: unchanged to higher

(+/-) Internet stocks: mixed

(+/-) Drug stocks: mixed

(-) Financial stocks: flat to lower

(-) Retail stocks: unchanged to lower

(+/-) Industrial stocks: mixed

(+) Airlines: higher

(+) Autos: higher


(+) GTIV (+62.9%) KND wants to buy co for $14/share

(+) SRC (+2.5%) Prices 23-million-share-sale at $10.69 each

(+) NWBO (+12.3%) DCVax trial shows promise on solid tumors

(+) VIPS (+6.2%) Extends gains on Q1 beat

(+) CLVS (+8.4%) To present cancer drugs data at ASCO meeting


(-) KSS (-2.9%) Q1 misses views

(-) BMY (-4.3%) BMO downgrades to market perform vs overweight

(-) SRNE (-21.8%) Price 4.8-million-share-sale at $5.25 each

(-) DK (-3.5%) Prices secondary 9.2-million-offering at $30 each

(-) DANG (-14.2%) Posts Q1 revenue miss, weak Q2 guidance

(-) SIR (-6.6%) Prices 9-mln-share-sale at 4.5% discount

(-) XONE (-14.4%) Misses on Q1 sales, loss widens

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.